Compositions And Methods For Treating Anemia

Patent No. EP3277270 (titled "Compositions And Methods For Treating Anemia") was filed by Akebia Therapeutics on Mar 31, 2016. The application was issued on Oct 27, 2021.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
SANDOZ	Jul 26, 2022	TER MEER STEINMEISTER & PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Jun 17, 2024
Communication to the parties concerning termination of the opposition proceedings - opposition rejected - no appeal lodged
Jun 17, 2024
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Mar 13, 2024
Annex to the communication - opposition
Mar 13, 2024
Brief communication - Opposition proceedings
Mar 13, 2024
Brief communication - Opposition proceedings
Mar 13, 2024
Decision of the Opposition Division and instruction
Mar 13, 2024
Decision rejecting the opposition
Mar 13, 2024
Decision rejecting the opposition
Mar 13, 2024
Grounds for the decision (Annex) - opposition
Mar 13, 2024
Means of redress
Mar 13, 2024
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
Mar 13, 2024
Minutes of the oral proceedings (Opposition Division) - introduction of the parties
Mar 13, 2024
Provision of a copy of the minutes - opposition procedure
Mar 13, 2024
Provision of a copy of the minutes - opposition procedure
Mar 13, 2024
Scanned annex to a communication - opposition procedure
Feb 6, 2024
Information about the result of oral proceedings
Dec 12, 2023
Brief communication - Opposition proceedings
Dec 11, 2023
Brief communication - Opposition proceedings
Dec 6, 2023
(Electronic) Receipt
Dec 6, 2023
(Electronic) Receipt
Dec 6, 2023
Auxiliary request during Opposition procedure
Dec 6, 2023
Auxiliary request during Opposition procedure
Dec 6, 2023
Auxiliary request during Opposition procedure
Dec 6, 2023
Auxiliary request during Opposition procedure
Dec 6, 2023
Auxiliary request during Opposition procedure
Dec 6, 2023
Auxiliary request during Opposition procedure
Dec 6, 2023
Auxiliary request during Opposition procedure - 01
Dec 6, 2023
Auxiliary request during Opposition procedure - 02
Dec 6, 2023
Auxiliary request during Opposition procedure - 03
Dec 6, 2023
Auxiliary request during Opposition procedure - 04
Dec 6, 2023
Auxiliary request during Opposition procedure - 05
Dec 6, 2023
Auxiliary request during Opposition procedure - 06
Dec 6, 2023
Letter accompanying subsequently filed items
Dec 6, 2023
Letter accompanying subsequently filed items
Dec 6, 2023
Request for interpreters during oral proceedings
Dec 6, 2023
Written submission in preparation to/during oral proceedings
Dec 4, 2023
Brief communication - Opposition proceedings
Nov 29, 2023
(Electronic) Receipt
Nov 29, 2023
Letter accompanying subsequently filed items
Nov 29, 2023
Request for interpreters during oral proceedings
May 15, 2023
Advice of delivery
May 12, 2023
Annex to the communication - opposition
May 12, 2023
Scanned annex to a communication - opposition procedure
May 12, 2023
Summons to attend oral proceedings
May 12, 2023
Summons to attend oral proceedings
May 12, 2023
Transmittal of decision / summons - opposition
May 12, 2023
Transmittal of decision / summons - opposition
Dec 22, 2022
Brief communication - Opposition proceedings
Dec 16, 2022
(Electronic) Receipt
Dec 16, 2022
Letter accompanying subsequently filed items
Dec 16, 2022
Reply of the patent proprietor to the notice(s) of opposition
Oct 7, 2022
Brief communication - Opposition proceedings
Oct 7, 2022
Communication confirming withdrawal from representation
Oct 7, 2022
Communication of amended entries concerning the representative
Sep 30, 2022
(Electronic) Receipt
Sep 30, 2022
Submission concerning change of proprietor's representative
Aug 8, 2022
Communication of a notice of opposition and request to file observations
Aug 8, 2022
Notice of further oppositions to opponent(s)
Aug 3, 2022
Communication of a notice of opposition - first information to patent proprietor
Jul 26, 2022
(Electronic) Receipt
Jul 26, 2022
Citation in opposition procedure - 001
Jul 26, 2022
Citation in opposition procedure - 002
Jul 26, 2022
Citation in opposition procedure - 003
Jul 26, 2022
Citation in opposition procedure - 004
Jul 26, 2022
Citation in opposition procedure - 005
Jul 26, 2022
Citation in opposition procedure - 006
Jul 26, 2022
Citation in opposition procedure - 007
Jul 26, 2022
Citation in opposition procedure - 008
Jul 26, 2022
Citation in opposition procedure - 009
Jul 26, 2022
Citation in opposition procedure - 010
Jul 26, 2022
Citation in opposition procedure - 011
Jul 26, 2022
Citation in opposition procedure - 012
Jul 26, 2022
Citation in opposition procedure - 013
Jul 26, 2022
Citation in opposition procedure - 014
Jul 26, 2022
Citation in opposition procedure - 015
Jul 26, 2022
Citation in opposition procedure - 016
Jul 26, 2022
Consolidated list of cited opposition documents
Jul 26, 2022
Notice of opposition
Jul 26, 2022
Notice of opposition
Nov 9, 2021
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Sep 30, 2021
Decision to grant a European patent
Sep 17, 2021
(Electronic) Receipt
Sep 17, 2021
French translation of claims
Sep 17, 2021
German translation of the claims
Sep 17, 2021
Letter accompanying subsequently filed items
May 25, 2021
Bibliographic data of the European patent application
May 25, 2021
Communication about intention to grant a European patent
May 25, 2021
Intention to grant (signatures)
May 25, 2021
Text intended for grant (clean copy)
May 25, 2021
Text intended for grant (version for approval)
Apr 26, 2021
(Electronic) Receipt
Apr 26, 2021
Amended claims with annotations
Apr 26, 2021
Claims
Apr 26, 2021
Description
Apr 26, 2021
Letter accompanying subsequently filed items
Apr 26, 2021
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Jan 20, 2021
Bibliographic data of the European patent application
Jan 20, 2021
Communication about intention to grant a European patent
Jan 20, 2021
Intention to grant (signatures)
Jan 20, 2021
Text intended for grant (clean copy)
Jan 20, 2021
Text intended for grant (version for approval)
May 14, 2020
(Electronic) Receipt
May 14, 2020
Amended claims with annotations
May 14, 2020
Claims
May 14, 2020
Description
May 14, 2020
Letter accompanying subsequently filed items
May 14, 2020
Reply to communication from the Examining Division
Jan 16, 2020
Annex to the communication
Jan 16, 2020
Communication from the Examining Division
Dec 19, 2019
Examination started
Apr 29, 2019
(Electronic) Receipt
Apr 29, 2019
Amended claims filed after receipt of (European) search report
Apr 29, 2019
Amended claims with annotations
Apr 29, 2019
Amendments received before examination
Apr 29, 2019
Letter accompanying subsequently filed items
Oct 19, 2018
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Oct 2, 2018
Communication regarding the transmission of the European search report
Oct 2, 2018
European search opinion
Oct 2, 2018
Information on Search Strategy
Oct 2, 2018
Supplementary European search report
May 16, 2018
(Electronic) Receipt
May 16, 2018
Amended claims filed after receipt of (European) search report
May 16, 2018
Amended claims with annotations
May 16, 2018
Amendments received before examination
May 16, 2018
Letter accompanying subsequently filed items
Jan 10, 2018
Notification on forthcoming publication of bibliographic data
Nov 8, 2017
Communication regarding possible amendment of the application/payment of claims fee
Nov 6, 2017
Communication to designated inventor
Nov 6, 2017
Communication to designated inventor
Nov 6, 2017
Communication to designated inventor
Nov 6, 2017
Communication to designated inventor
Nov 6, 2017
Communication to designated inventor
Nov 6, 2017
Communication to designated inventor
Nov 6, 2017
Communication to designated inventor
Oct 13, 2017
(Electronic) Receipt
Oct 13, 2017
Annex
Oct 13, 2017
Copy of the international preliminary report on patentability
Oct 13, 2017
Request for entry into the European phase
Aug 11, 2017
Information on entry into European phase
Oct 27, 2016
Priority document (electronically transmitted)
Oct 27, 2016
Priority document (electronically transmitted)
Oct 6, 2016
Copy of the international search report
Oct 6, 2016
Published international application - A1

EP3277270

AKEBIA THERAPEUTICS

Application Number: EP16774184A
Filing Date: Mar 31, 2016
Status: Opposition Rejected; Jun 14, 2024
Publication Date: Oct 27, 2021
External Links: Slate, Register , Google Patents

IP Verse

Compositions And Methods For Treating Anemia

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3277270